Get access to our workshop by completing this short webform

Laboratories are being told that COVID-19 testing volumes must increase to help restore our communities back to some degree of normality. But how can laboratories scale while minimizing costs, and with the confidence of assurance of uninterrupted supply of tests and reagents? Introducing the upcoming Thermo Fisher Scientific Amplitude Solution—a highly-automated molecular diagnostic testing system that can analyze over 6,000 specimens in a single day with the reliability and confidence of assured assay and reagent supply, along with 24/7 world class service and support. Attend this workshop to see the performance data and hear from early-access customers.

Speakers:

• Mark Stevenson, Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific • Robert Balog, Director, Engineering Systems Design, Thermo Fisher Scientific • Elliot Shelton, Senior Director, High Throughput Program Manaement, Thermo Fisher Scientific

 

(*Indicates a mandatory field)

First name*

Last name*

Institution*

City*

Country/Region*

Please selectCanadaUnited States

Email*

Is your lab currently performing COVID-19 testing?*

Yes

No

Is your lab performing COVID-19 samples*

Yes

No

How many COVID-19 samples per day is your lab currently performing?

If your lab looking to scale?*

Yes

No

What volume is your lab looking to scale to per day?

Is your laboratory wanting to implement a high-throughput, highly-automated molecular testing system in the next 6 months?*

Yes

No

0-2 months

2-4 months

4+ months

Register

The content provided herein may relate to products or workflows that have not been officially CE Marked, authorized by the US FDA or global health agencies, and is subject to change without notice; Refer to current user manual for indications, warning and precautions. All validation data to support the Thermo Fisher Scientific Amplitude Solution has been completed and is currently under review by the Food and Drug Administration. Use of Thermo Fisher Scientific Amplitude Solution is permitted per FDA Policy for Coronavirus Disease-2019 Test during the Public Health Emergency (Revised) released on May 11, 2020.